Argeloside A
- Family: Plantae - Apocynaceae
- Kingdom: Plantae
-
Class: Steroid
- Subclass: Pregnane Glycoside
Canonical Smiles | CO[C@@H]1C[C@@H](OC([C@H]1O[C@H]1C[C@@H](OC)[C@@H](C(O1)C)O[C@@H]1OC(C)[C@H]([C@@H](C1O)OC)O[C@@H]1OC(CO)[C@H]([C@@H](C1O)O)O)C)O[C@H]1[C@H](O)C[C@@H](OC1C)O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@@]43O[C@H]3[C@@H]2[C@](O4)(C)OC3)C)C1)COC(=O)C |
---|---|
InChI | InChI=1S/C56H88O24/c1-24-45(33(59)18-38(69-24)73-30-13-16-55(23-67-28(5)58)29(17-30)11-12-32-31(55)14-15-53(6)50-37-22-68-54(50,7)80-56(32,53)79-37)75-39-19-34(64-8)46(25(2)70-39)76-40-20-35(65-9)47(26(3)71-40)77-52-44(63)49(66-10)48(27(4)72-52)78-51-43(62)42(61)41(60)36(21-57)74-51/h11,24-27,30-52,57,59-63H,12-23H2,1-10H3/t24?,25?,26?,27?,30-,31-,32+,33+,34+,35+,36?,37+,38-,39-,40-,41+,42-,43?,44?,45+,46+,47+,48+,49+,50-,51-,52-,53+,54+,55+,56-/m0/s1 |
InChIKey | NUHQNAFCQWNZHH-KKUBQSGSSA-N |
Formula | C56H88O24 |
HBA | 24 |
HBD | 6 |
MW | 1145.3 |
Rotatable Bonds | 16 |
TPSA | 295.36 |
LogP | 1.21 |
Number Rings | 11 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 80 |
Formal Charge | 0 |
Fraction CSP3 | 0.95 |
Exact Mass | 1144.57 |
Number of Lipinski Rule Violations | 3 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Solenostemma argel | Apocynaceae | Plantae | 219273 |
2 | Solenostemma argel | Apocynaceae | Plantae | 219273 |
Showing of synonyms
- Plaza A, Bifulco G, et al. (2003). Argeloside A and B, two novel 14,15-secopregnane glycosides from Solenostemma argel. Tetrahedron Letters,2003,44(47),8553-8558. [View]
- Plaza A, Perrone A, et al. (2005). New antiproliferative 14,15-secopregnane glycosides from Solenostemma argel. Tetrahedron,2005,61(31),7470-7480. [View]
No compound-protein relationship available.
SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCC(C6)OC(OC7)CCC7OC(OC8)CCC8OC(OC9)CCC9OC(OC1)CCC1OC1CCCCO1
Level: 5
Mol. Weight: 1145.3 g/mol
SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCC(C6)OC(OC7)CCC7OC(OC8)CCC8OC(OC9)CCC9OC1CCCCO1
Level: 4
Mol. Weight: 1145.3 g/mol
SMILES: O1CCCCC1OC2CCC(OC2)OC3CCC(OC3)OC4CCC(OC4)OC5CCCOC5
Level: 4
Mol. Weight: 1145.3 g/mol
SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCC(C6)OC(OC7)CCC7OC(OC8)CCC8OC9CCCCO9
Level: 3
Mol. Weight: 1145.3 g/mol
SMILES: C1OCCCC1OC(OC2)CCC2OC(OC3)CCC3OC4CCCCO4
Level: 3
Mol. Weight: 1145.3 g/mol
SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCC(C6)OC(OC7)CCC7OC8CCCCO8
Level: 2
Mol. Weight: 1145.3 g/mol
SMILES: O1CCCCC1OC2CCC(OC2)OC3CCCOC3
Level: 2
Mol. Weight: 1145.3 g/mol
SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCC(C6)OC7CCCCO7
Level: 1
Mol. Weight: 1145.3 g/mol
SMILES: C1OCCCC1OC2CCCCO2
Level: 1
Mol. Weight: 1145.3 g/mol
SMILES: O1C2OCC(O3)C2C(C134)CCC5C4CC=C6C5CCCC6
Level: 0
Mol. Weight: 1145.3 g/mol
SMILES: C1CCOCC1
Level: 0
Mol. Weight: 1145.3 g/mol
Absorption
- Caco-2 (logPapp)
- -5.93
- Human Oral Bioavailability 20%
- Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- 31425332.690
- Human Oral Bioavailability 50%
- Non-Bioavailable
- P-Glycoprotein Inhibitor
- Non-Inhibitor
- P-Glycoprotein Substrate
- Substrate
- Skin Permeability
- 4106922580.62
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Non-Penetrable
- Fraction Unbound (Human)
- 0.560
- Plasma Protein Binding
- 84.19
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Non-Inhibitor
- CYP 1A2 Inhibitor
- Non-Inhibitor
- CYP 1A2 Substrate
- Non-Substrate
- CYP 2C19 Inhibitor
- Non-Inhibitor
- CYP 2C19 Substrate
- Non-Substrate
- CYP 2C9 Inhibitor
- Non-Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Substrate
- OATP1B1
- Non-Inhibitor
- OATP1B3
- Inhibitor
Excretion
- Clearance
- 3.120
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Toxic
- Bee
- Safe
- Bioconcentration Factor
- -95517712.140
- Biodegradation
- Toxic
- Carcinogenesis
- Safe
- Crustacean
- Toxic
- Liver Injury I (DILI)
- Safe
- Eye Corrosion
- Safe
- Eye Irritation
- Safe
- Maximum Tolerated Dose
- -39.820
- Liver Injury II
- Safe
- hERG Blockers
- Toxic
- Daphnia Maga
- 4.050
- Micronucleos
- Toxic
- NR-AhR
- Safe
- NR-AR
- Safe
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Toxic
- NR-PPAR-gamma
- Safe
- NR-TR
- Safe
- T. Pyriformis
- -7453866696861.420
- Rat (Acute)
- 4.340
- Rat (Chronic Oral)
- 15989.180
- Fathead Minnow
- 9408923493.470
- Respiratory Disease
- Toxic
- Skin Sensitisation
- Safe
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Toxic
- SR-p53
- Safe
General Properties
- Boiling Point
- 838353282126.740
- Hydration Free Energy
- -2.920
- Log(D) at pH=7.4
- -466021.840
- Log(P)
- -51.78
- Log S
- -4.0
- Log(Vapor Pressure)
- -27606552148.13
- Melting Point
- -5813.15
- pKa Acid
- -201157187.71
- pKa Basic
- -1618288.67
Protein Name | UniProt ID | Entry Name | Species | #Pharmacophore Points | Probability (0.7 ≤ Tversky Score ≤ 1.0) |
---|---|---|---|---|---|
Aldo-keto reductase family 1 member D1 | P51857 | AK1D1_HUMAN | Homo sapiens | 3 | 0.7670 |
Aldo-keto reductase family 1 member D1 | P51857 | AK1D1_HUMAN | Homo sapiens | 3 | 0.7670 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | P04191 | AT2A1_RABIT | Oryctolagus cuniculus | 3 | 0.7098 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | P04191 | AT2A1_RABIT | Oryctolagus cuniculus | 3 | 0.7098 |